88 related articles for article (PubMed ID: 21930127)
1. Long isoform of ErbB3 binding protein, p48, mediates protein kinase B/Akt-dependent HDM2 stabilization and nuclear localization.
Kim CK; Lee SB; Nguyen TL; Lee KH; Um SH; Kim J; Ahn JY
Exp Cell Res; 2012 Jan; 318(2):136-43. PubMed ID: 21930127
[TBL] [Abstract][Full Text] [Related]
2. Negative regulation of p53 by the long isoform of ErbB3 binding protein Ebp1 in brain tumors.
Kim CK; Nguyen TL; Joo KM; Nam DH; Park J; Lee KH; Cho SW; Ahn JY
Cancer Res; 2010 Dec; 70(23):9730-41. PubMed ID: 21098709
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C epsilon confers resistance of MCF-7 cells to TRAIL by Akt-dependent activation of Hdm2 and downregulation of p53.
Shankar E; Sivaprasad U; Basu A
Oncogene; 2008 Jun; 27(28):3957-66. PubMed ID: 18317451
[TBL] [Abstract][Full Text] [Related]
4. Ebp1 p48 promotes oncogenic activities in human colon cancer cells through regulation of TIF-90-mediated ribosomal RNA synthesis.
Nguyen DQ; Hoang DH; Nguyen TTV; Ho HD; Huynh V; Shin JH; Ly QT; Thi Nguyen DD; Ghoda L; Marcucci G; Nguyen LXT
J Cell Physiol; 2019 Aug; 234(10):17612-17621. PubMed ID: 30793766
[TBL] [Abstract][Full Text] [Related]
5. Hdm2 is a ubiquitin ligase of Ku70-Akt promotes cell survival by inhibiting Hdm2-dependent Ku70 destabilization.
Gama V; Gomez JA; Mayo LD; Jackson MW; Danielpour D; Song K; Haas AL; Laughlin MJ; Matsuyama S
Cell Death Differ; 2009 May; 16(5):758-69. PubMed ID: 19247369
[TBL] [Abstract][Full Text] [Related]
6. Opposing roles of the two isoforms of ErbB3 binding protein 1 in human cancer cells.
Ko HR; Chang YS; Park WS; Ahn JY
Int J Cancer; 2016 Sep; 139(6):1202-8. PubMed ID: 27130196
[TBL] [Abstract][Full Text] [Related]
7. The oncoprotein SS18-SSX1 promotes p53 ubiquitination and degradation by enhancing HDM2 stability.
D'Arcy P; Maruwge W; Ryan BA; Brodin B
Mol Cancer Res; 2008 Jan; 6(1):127-38. PubMed ID: 18234968
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylation of the N-terminal domain of p48 Ebp1 by CDK2 is required for tumorigenic function of p48.
Ko HR; Kim CK; Ahn JY
Mol Carcinog; 2015 Nov; 54(11):1283-91. PubMed ID: 25154617
[TBL] [Abstract][Full Text] [Related]
9. Interferon-inducible protein IFIXalpha1 functions as a negative regulator of HDM2.
Ding Y; Lee JF; Lu H; Lee MH; Yan DH
Mol Cell Biol; 2006 Mar; 26(5):1979-96. PubMed ID: 16479015
[TBL] [Abstract][Full Text] [Related]
10. EBP1 protein modulates the expression of human MHC class II molecules in non-hematopoietic cancer cells.
Pisapia L; Barba P; Cortese A; Cicatiello V; Morelli F; Del Pozzo G
Int J Oncol; 2015 Aug; 47(2):481-9. PubMed ID: 26081906
[TBL] [Abstract][Full Text] [Related]
11. Ebp1 isoforms distinctively regulate cell survival and differentiation.
Liu Z; Ahn JY; Liu X; Ye K
Proc Natl Acad Sci U S A; 2006 Jul; 103(29):10917-22. PubMed ID: 16832058
[TBL] [Abstract][Full Text] [Related]
12. SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival.
Fenouille N; Puissant A; Tichet M; Zimniak G; Abbe P; Mallavialle A; Rocchi S; Ortonne JP; Deckert M; Ballotti R; Tartare-Deckert S
Oncogene; 2011 Dec; 30(49):4887-900. PubMed ID: 21685937
[TBL] [Abstract][Full Text] [Related]
13. Specific domains of nucleolin interact with Hdm2 and antagonize Hdm2-mediated p53 ubiquitination.
Bhatt P; d'Avout C; Kane NS; Borowiec JA; Saxena A
FEBS J; 2012 Feb; 279(3):370-83. PubMed ID: 22103682
[TBL] [Abstract][Full Text] [Related]
14. Phosphorylation of HDM2 by Akt.
Ashcroft M; Ludwig RL; Woods DB; Copeland TD; Weber HO; MacRae EJ; Vousden KH
Oncogene; 2002 Mar; 21(13):1955-62. PubMed ID: 11960368
[TBL] [Abstract][Full Text] [Related]
15. Loss of HAUSP-mediated deubiquitination contributes to DNA damage-induced destabilization of Hdmx and Hdm2.
Meulmeester E; Maurice MM; Boutell C; Teunisse AF; Ovaa H; Abraham TE; Dirks RW; Jochemsen AG
Mol Cell; 2005 May; 18(5):565-76. PubMed ID: 15916963
[TBL] [Abstract][Full Text] [Related]
16. Hdm2 nuclear export, regulated by insulin-like growth factor-I/MAPK/p90Rsk signaling, mediates the transformation of human cells.
Jackson MW; Patt LE; LaRusch GA; Donner DB; Stark GR; Mayo LD
J Biol Chem; 2006 Jun; 281(24):16814-20. PubMed ID: 16621805
[TBL] [Abstract][Full Text] [Related]
17. MNK1 and EIF4E are downstream effectors of MEKs in the regulation of the nuclear export of HDM2 mRNA.
Phillips A; Blaydes JP
Oncogene; 2008 Mar; 27(11):1645-9. PubMed ID: 17828301
[TBL] [Abstract][Full Text] [Related]
18. Cyclooxygenase inhibitors modulate the p53/HDM2 pathway and enhance chemotherapy-induced apoptosis in neuroblastoma.
Lau L; Hansford LM; Cheng LS; Hang M; Baruchel S; Kaplan DR; Irwin MS
Oncogene; 2007 Mar; 26(13):1920-31. PubMed ID: 16983334
[TBL] [Abstract][Full Text] [Related]
19. p53-independent activation of the hdm2-P2 promoter through multiple transcription factor response elements results in elevated hdm2 expression in estrogen receptor alpha-positive breast cancer cells.
Phelps M; Darley M; Primrose JN; Blaydes JP
Cancer Res; 2003 May; 63(10):2616-23. PubMed ID: 12750288
[TBL] [Abstract][Full Text] [Related]
20. Identification of an aberrantly spliced form of HDMX in human tumors: a new mechanism for HDM2 stabilization.
Giglio S; Mancini F; Gentiletti F; Sparaco G; Felicioni L; Barassi F; Martella C; Prodosmo A; Iacovelli S; Buttitta F; Farsetti A; Soddu S; Marchetti A; Sacchi A; Pontecorvi A; Moretti F
Cancer Res; 2005 Nov; 65(21):9687-94. PubMed ID: 16266988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
